Nordea Investment Management
AGIO icon

Nordea Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Nordea Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-224,746
Closed -$7.52M – 847
2025
Q2 		$7.52M Buy
224,746
+573
+0.3% +$17.4K 0.01% 475
2025
Q1 		$6.51M Buy
224,173
+3,604
+2% +$120K 0.01% 481
2024
Q4 		$7.19M Buy
220,569
+7,593
+4% +$357K 0.01% 476
2024
Q3 		$9.71M Sell
212,976
-11,879
-5% -$539K 0.01% 416
2024
Q2 		$9.87M Sell
224,855
-41,733
-16% -$1.51M 0.01% 405
2024
Q1 		$7.82M Buy
266,588
+30,764
+13% +$824K 0.01% 463
2023
Q4 		$5.28M Sell
235,824
-6,146
-3% -$138K 0.01% 512
2023
Q3 		$6.06M Sell
241,970
-5,373
-2% -$142K 0.01% 458
2023
Q2 		$6.97M Sell
247,343
-59,100
-19% -$1.47M 0.01% 449
2023
Q1 		$7.08M Buy
+306,443
New +$8.14M 0.01% 448

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Nordea Investment Management's AGIO Position: Q3 2025 in Review

Nordea Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2025, closing a stake of 224,746 shares — an estimated $7.52M sold.

Nordea Investment Management first reported a position in AGIO in Q1 2023 and held it in 10 quarters. The position peaked at $9.87M in Q2 2024. 220 funds tracked by Wall St. Rank hold AGIO as of Q3 2025.

  • Nordea Investment Management reported no remaining Agios Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Nordea Investment Management sold 224,746 Agios Pharmaceuticals shares in Q3 2025, an estimated $7.52M.
  • Nordea Investment Management first reported a position in Agios Pharmaceuticals in Q1 2023 and held it in 10 quarters.
  • Nordea Investment Management's Agios Pharmaceuticals position peaked at $9.87M in Q2 2024.
  • 220 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2025.

Based on Nordea Investment Management's 13F filing for Q3 2025, filed 27 Oct 2025.